Assignee
CELLESTIS LTD
AU·9 granted patents·4 pending applications·14 citations·filing 2003–2025
Top patents by PatentIndex Score
13 records- 0186US2025093352A1Use of amino acid sequences from mycobacterium tuberculosis or corresponding nucleic acids for diagnosis and prevention of tubercular infection, diagnostic kit and vaccine therefromCELLESTIS LTD·Filed 2024·Application pending·0 cites
- 0277US12181476B2Use of amino acid sequences from Mycobacterium tuberculosis or corresponding nucleic acids for diagnosis and prevention of tubercular infection, diagnostic kit and vaccine therefromCELLESTIS LTD·Filed 2022·Granted Dec 31, 2024·0 cites·15 claims
- 0373US10788491B2Use of amino acid sequences from Mycobacterium tuberculosis or corresponding nucleic acids for diagnosis and prevention of tubercular infection, diagnostic kit and vaccine therefromCELLESTIS LTD·Filed 2019·Granted Sep 29, 2020·0 cites·2 claims
- 0470US11275086B2Use of amino acid sequences from Mycobacterium tuberculosis or corresponding nucleic acids for diagnosis and prevention of tubercular infection, diagnostic kit and vaccine therefromCELLESTIS LTD·Filed 2020·Granted Mar 15, 2022·0 cites·2 claims
- 0570US2025369968A1Cell mediated immune response assay with enhanced sensitivityCELLESTIS LTD·Filed 2025·Application pending·0 cites
- 0666US10564150B2Cell mediated immune response assayCELLESTIS LTD·Filed 2013·Granted Feb 18, 2020·1 cites·14 claims
- 0764US7608392B2Diagnostic assay for measuring a cell mediated immune responseCELLESTIS LTD·Filed 2003·Granted Oct 27, 2009·13 cites·64 claims
- 0862US11841367B2TLR agonist-enhanced in vitro assay of cell mediated immune responsivenessCELLESTIS LTD·Filed 2019·Granted Dec 12, 2023·0 cites·16 claims
- 0962US2019101536A1Cell mediated immune response assay with enhanced sensitivityCELLESTIS LTD·Filed 2018·Application pending·0 cites
- 1061US10408833B2Use of amino acid sequences from Mycobacterium tuberculosis or corresponding nucleic acids for diagnosis and prevention of tubercular infection, diagnostic kit and vaccine therefromCELLESTIS LTD·Filed 2017·Granted Sep 10, 2019·0 cites·2 claims
- 1156US2025369957A1Cell mediated immune response assayCELLESTIS LTD·Filed 2025·Application pending·0 cites
- 1255US12153042B2Cell mediated immune response assayCELLESTIS LTD·Filed 2020·Granted Nov 26, 2024·0 cites·10 claims
- 1355US9829490B2Use of amino acid sequences from Mycobacterium tuberculosis or corresponding nucleic acids for diagnosis and prevention of tubercular infection, diagnostic kit and vaccine therefromCELLESTIS LTD·Filed 2015·Granted Nov 28, 2017·0 cites·2 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →